Role of long noncoding RNA taurine‐upregulated gene 1 in cancers

Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 ( TUG1 ) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by speci...

Full description

Saved in:
Bibliographic Details
Published in:Molecular medicine (Cambridge, Mass.) Vol. 27; no. 1; pp. 51 - 17
Main Authors: Da, Miao, Zhuang, Jing, Zhou, Yani, Qi, Quan, Han, Shuwen
Format: Journal Article
Language:English
Published: London BioMed Central 26.05.2021
Springer Nature B.V
BMC
Subjects:
Angiogenesis
Animals
Apoptosis
Apoptosis - genetics
Biomarker
Biomarkers, Tumor
Biomedical and Life Sciences
Biomedicine
Bladder cancer
Bone cancer
Breast cancer
Cancer
Cell Cycle
Cell division
Cell growth
Cell Line, Tumor
Cell Movement
Cell Proliferation
Chemotherapy
Competitive endogenous RNA (ceRNA)
Cyclin-dependent kinases
Disease Susceptibility
Drug resistance
Epigenetics
Gene Expression Regulation, Neoplastic - drug effects
Humans
Kidney cancer
Kinases
Long non-coding RNA (lncRNA)
Lung cancer
Metastasis
MicroRNAs
Molecular Medicine
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Neoplasms - therapy
Neovascularization, Pathologic - genetics
Neovascularization, Pathologic - metabolism
Pancreatic cancer
Prostate cancer
Review
RNA, Long Noncoding - genetics
Signal Transduction
Taurine‐upregulated gene 1 (TUG1)
Vascular endothelial growth factor
)
Biomarker
Competitive endogenous RNA (ceRNA)
Long non-coding RNA (lncRNA)
Taurine‐upregulated gene 1
Cancer
Taurine‐upregulated gene 1 (TUG1)
ISSN:1076-1551, 1528-3658, 1528-3658
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 ( TUG1 ) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by specifically sponging its corresponding microRNAs. In the present review, we summarised the current understanding of the role of lncRNA TUG1 in cancer cell proliferation, metastasis, angiogenesis, chemotherapeutic drug resistance, radiosensitivity, cell regulation, and cell glycolysis, as well as highlighting its potential application as a clinical biomarker or therapeutic target for malignant cancer. This review provides the basis for new research directions for lncRNA TUG1 in cancer prevention, diagnosis, and treatment.
AbstractList Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 ( TUG1 ) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by specifically sponging its corresponding microRNAs. In the present review, we summarised the current understanding of the role of lncRNA TUG1 in cancer cell proliferation, metastasis, angiogenesis, chemotherapeutic drug resistance, radiosensitivity, cell regulation, and cell glycolysis, as well as highlighting its potential application as a clinical biomarker or therapeutic target for malignant cancer. This review provides the basis for new research directions for lncRNA TUG1 in cancer prevention, diagnosis, and treatment.
Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 (TUG1) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by specifically sponging its corresponding microRNAs. In the present review, we summarised the current understanding of the role of lncRNA TUG1 in cancer cell proliferation, metastasis, angiogenesis, chemotherapeutic drug resistance, radiosensitivity, cell regulation, and cell glycolysis, as well as highlighting its potential application as a clinical biomarker or therapeutic target for malignant cancer. This review provides the basis for new research directions for lncRNA TUG1 in cancer prevention, diagnosis, and treatment.
Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 (TUG1) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by specifically sponging its corresponding microRNAs. In the present review, we summarised the current understanding of the role of lncRNA TUG1 in cancer cell proliferation, metastasis, angiogenesis, chemotherapeutic drug resistance, radiosensitivity, cell regulation, and cell glycolysis, as well as highlighting its potential application as a clinical biomarker or therapeutic target for malignant cancer. This review provides the basis for new research directions for lncRNA TUG1 in cancer prevention, diagnosis, and treatment.Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 (TUG1) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by specifically sponging its corresponding microRNAs. In the present review, we summarised the current understanding of the role of lncRNA TUG1 in cancer cell proliferation, metastasis, angiogenesis, chemotherapeutic drug resistance, radiosensitivity, cell regulation, and cell glycolysis, as well as highlighting its potential application as a clinical biomarker or therapeutic target for malignant cancer. This review provides the basis for new research directions for lncRNA TUG1 in cancer prevention, diagnosis, and treatment.
Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 (TUG1) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by specifically sponging its corresponding microRNAs. In the present review, we summarised the current understanding of the role of lncRNA TUG1 in cancer cell proliferation, metastasis, angiogenesis, chemotherapeutic drug resistance, radiosensitivity, cell regulation, and cell glycolysis, as well as highlighting its potential application as a clinical biomarker or therapeutic target for malignant cancer. This review provides the basis for new research directions for lncRNA TUG1 in cancer prevention, diagnosis, and treatment.
Abstract Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 (TUG1) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by specifically sponging its corresponding microRNAs. In the present review, we summarised the current understanding of the role of lncRNA TUG1 in cancer cell proliferation, metastasis, angiogenesis, chemotherapeutic drug resistance, radiosensitivity, cell regulation, and cell glycolysis, as well as highlighting its potential application as a clinical biomarker or therapeutic target for malignant cancer. This review provides the basis for new research directions for lncRNA TUG1 in cancer prevention, diagnosis, and treatment.
ArticleNumber 51
Author Qi, Quan
Da, Miao
Han, Shuwen
Zhuang, Jing
Zhou, Yani
Author_xml – sequence: 1
  givenname: Miao
  surname: Da
  fullname: Da, Miao
  organization: Department of Nursing, Huzhou Third Municipal Hospital
– sequence: 2
  givenname: Jing
  surname: Zhuang
  fullname: Zhuang, Jing
  organization: Medical College of Nursing, Huzhou University
– sequence: 3
  givenname: Yani
  surname: Zhou
  fullname: Zhou, Yani
  organization: Graduate School of Medicine Faculty, Zhejiang University
– sequence: 4
  givenname: Quan
  surname: Qi
  fullname: Qi, Quan
  organization: Department of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University
– sequence: 5
  givenname: Shuwen
  orcidid: 0000-0001-6180-9565
  surname: Han
  fullname: Han, Shuwen
  email: ww@hzhospital.com
  organization: Department of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34039257$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1TAQhiNURC_wAixQJDZsUny3s0EqFZdKFUgVrC3HHgcf5dgHO0FixyPwjDwJbtMW2kVXHtnf_88vzxw2ezFFaJrnGB1jrMTrghEiqEMEdwhRTDr2qDnAnKiOCq72ao2k6DDneL85LGVTacwZf9LsU4ZoT7g8aN5epAna5NspxbGtDWxyoVYXn07a2Sw5RPjz6_eyyzAuk5nBtSNEaHEbYmtNtJDL0-axN1OBZ9fnUfP1_bsvpx-7888fzk5PzjsrkZw7qwgSakA9tYPBzjgvPaO493agA_EMes-BUSkUdw5xh7yUA_KYEd8rJhE9as5WX5fMRu9y2Jr8UycT9NVFyqM2eQ52Au0APGPGYUkUU7TvrVLccN4rMfRoUNXrzeq1W4YtOAtxzma6Y3r3JYZvekw_tMJcCsGrwatrg5y-L1BmvQ3FwjSZCGkpmnBKKRaY9hV9eQ_dpCXH-lWVYoIIyrio1Iv_E91GuRlVBdQK2JxKyeC1DbOZQ7oMGCaNkb7cCr1uha6z1ldboVmVknvSG_cHRXQVlQrHEfK_2A-o_gI5D8hr
CitedBy_id crossref_primary_10_1038_s41435_025_00358_y
crossref_primary_10_1007_s12094_022_02876_x
crossref_primary_10_3389_fmolb_2025_1566551
crossref_primary_10_1007_s12035_025_05131_w
crossref_primary_10_3389_fcvm_2025_1522544
crossref_primary_10_1186_s12929_024_01049_y
crossref_primary_10_1111_jog_15363
crossref_primary_10_1007_s11306_023_02038_2
crossref_primary_10_3390_cimb47090698
crossref_primary_10_3390_ijms25010560
crossref_primary_10_1016_j_lfs_2022_120974
crossref_primary_10_20935_AcadBiol7706
crossref_primary_10_3389_fmed_2022_803214
crossref_primary_10_1016_j_semcdb_2023_02_007
crossref_primary_10_2217_epi_2023_0242
crossref_primary_10_3389_fphar_2022_885075
crossref_primary_10_3389_fphar_2024_1405199
crossref_primary_10_1371_journal_pone_0329490
crossref_primary_10_2174_0115665240298173240427042624
crossref_primary_10_3389_fcimb_2023_1160198
crossref_primary_10_1177_15330338241292226
crossref_primary_10_3389_fphar_2025_1551258
crossref_primary_10_1111_cas_16150
crossref_primary_10_3390_life14111430
Cites_doi 10.1016/j.ygeno.2020.08.005
10.3748/wjg.v26.i6.627
10.3390/cells9040828
10.1111/cas.14685
10.1186/s13046-020-01742-4
10.1038/s41419-021-03645-4
10.1007/s13277-016-5391-5
10.1186/s13014-017-0802-3
10.1097/MD.0000000000010575
10.1002/path.2638
10.3727/096504016X14783677992682
10.1186/s13578-018-0260-0
10.1186/s12885-016-2569-6
10.3233/CBM-181405
10.3727/096504017X14908298412505
10.2147/CMAR.S256624
10.1007/s11010-020-03751-5
10.1111/cas.13201
10.1038/s41419-020-2254-1
10.1007/s10620-019-05911-0
10.1111/jop.12599
10.3349/ymj.2018.59.2.226
10.3727/096504018X15152085755247
10.1016/j.biopha.2018.11.003
10.1038/s41556-019-0311-8
10.1016/j.biocel.2018.05.010
10.1016/j.clinbiochem.2020.06.005
10.1016/j.biopha.2017.09.076
10.1186/s12935-019-1093-6
10.2147/CMAR.S270515
10.12659/MSM.897072
10.1038/s41467-020-17667-7
10.1042/BSR20180677
10.1111/1440-1681.13375
10.1038/s41419-019-1509-1
10.3892/or.2020.7623
10.2147/OTT.S217795
10.2147/OTT.S254634
10.1007/s00277-018-3315-8
10.4103/0973-1482.172585
10.1016/j.biopha.2017.12.004
10.1002/cam4.994
10.1007/s00280-016-3066-y
10.1002/jcb.27284
10.1093/abbs/gmz069
10.1016/j.bbrc.2016.06.129
10.1002/cbf.3575
10.1097/CAD.0000000000000734
10.1080/1061186X.2019.1644651
10.1159/000492517
10.1093/carcin/bgaa110
10.1177/1535370215622708
10.1016/j.gene.2018.06.085
10.1038/cddis.2014.201
10.1016/j.bbrc.2017.01.145
10.1016/j.gene.2017.01.024
10.18632/oncotarget.21922
10.1016/j.ygeno.2019.04.020
10.1016/j.canlet.2020.10.031
10.1007/s00011-020-01388-0
10.1186/s12885-019-5435-5
10.1159/000493876
10.4048/jbc.2016.19.4.349
10.1111/1759-7714.13236
10.1016/j.lfs.2019.117035
10.1097/CAD.0000000000000882
10.1007/s10456-018-9658-x
10.1159/000479990
10.3390/cells9020262
10.2147/CMAR.S200998
10.2147/OTT.S240434
10.2147/OTT.S236860
10.1139/bcb-2020-0017
10.1016/j.omtn.2019.02.017
10.1016/j.cub.2005.02.027
10.1038/nature10887
10.2147/OTT.S188396
10.2147/OTT.S238189
10.4149/neo_2020_190805N717
10.1016/j.taap.2019.04.005
10.1016/j.exphem.2019.10.002
10.1002/jcb.28614
10.1002/jcla.23540
10.1007/s13277-014-2763-6
10.1097/CEJ.0000000000000594
10.1111/cas.13765
10.1186/s12935-020-01474-7
10.1097/MD.0000000000012131
10.1016/j.semcdb.2012.02.003
10.1002/ar.24367
10.1007/s10529-020-02984-0
10.2147/OTT.S136386
10.1016/j.ejphar.2019.172536
10.3233/CBM-181834
10.18632/oncotarget.10563
10.1016/j.bbrc.2018.12.011
ContentType Journal Article
Copyright The Author(s) 2021
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Copyright_xml – notice: The Author(s) 2021
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s10020-021-00312-4
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
ProQuest Health & Medical Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1528-3658
EndPage 17
ExternalDocumentID oai_doaj_org_article_deef44ad172848399c885a55986b90b8
PMC8157665
34039257
10_1186_s10020_021_00312_4
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Zhejiang Provincial Natural Science Foundation and Zhejiang Medical and Health Technology Projects
  grantid: No.LQ20H160001; No.2020RC117
– fundername: ;
  grantid: No.LQ20H160001; No.2020RC117
GroupedDBID ---
-ET
0R~
123
29M
2WC
36B
5RE
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABUWG
ACGFO
ACMJI
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
IAO
IH2
IHR
ISR
ITC
KQ8
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PUEGO
RBZ
RNS
ROL
RPM
RSV
SDH
SJN
SOJ
SV3
TR2
UKHRP
WOQ
AAYXX
AFFHD
CITATION
ACRMQ
ALIPV
C24
CGR
CUY
CVF
ECM
EIF
M~E
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c707t-c82068b093cba1dadf7f4319fcb3b2f4e9f5e437685dd05d0f77b0f142f984703
IEDL.DBID RSV
ISICitedReferencesCount 29
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000655107800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1076-1551
1528-3658
IngestDate Fri Oct 03 12:52:39 EDT 2025
Tue Nov 04 01:58:34 EST 2025
Fri Sep 05 06:08:29 EDT 2025
Sun Oct 19 01:37:17 EDT 2025
Thu Jan 02 22:56:45 EST 2025
Sat Nov 29 02:40:44 EST 2025
Tue Nov 18 20:25:00 EST 2025
Sat Sep 06 07:22:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords )
Biomarker
Competitive endogenous RNA (ceRNA)
Long non-coding RNA (lncRNA)
Taurine‐upregulated gene 1
Cancer
Taurine‐upregulated gene 1 (TUG1)
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c707t-c82068b093cba1dadf7f4319fcb3b2f4e9f5e437685dd05d0f77b0f142f984703
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-6180-9565
OpenAccessLink https://link.springer.com/10.1186/s10020-021-00312-4
PMID 34039257
PQID 2546263456
PQPubID 5066171
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_deef44ad172848399c885a55986b90b8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8157665
proquest_miscellaneous_2533316139
proquest_journals_2546263456
pubmed_primary_34039257
crossref_citationtrail_10_1186_s10020_021_00312_4
crossref_primary_10_1186_s10020_021_00312_4
springer_journals_10_1186_s10020_021_00312_4
PublicationCentury 2000
PublicationDate 20210526
PublicationDateYYYYMMDD 2021-05-26
PublicationDate_xml – month: 5
  year: 2021
  text: 20210526
  day: 26
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
PublicationTitle Molecular medicine (Cambridge, Mass.)
PublicationTitleAbbrev Mol Med
PublicationTitleAlternate Mol Med
PublicationYear 2021
Publisher BioMed Central
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: Springer Nature B.V
– name: BMC
References Li Jun (312_CR32) 2016; 477
L Gang (312_CR19) 2018; 59
Li Gang (312_CR20) 2019; 12
Q Jun (312_CR33) 2018; 23
G Peng (312_CR59) 2018; 26
B Ji-Yu (312_CR30) 2021; 498
H Tongzhou (312_CR74) 2019; 371
Li Heng (312_CR25) 2018; 16
Hu Yu Xiao (312_CR98) 2019; 10
TL Young (312_CR97) 2005; 15
Li Gang (312_CR21) 2020; 31
W Zhifeng (312_CR109) 2020; 26
S Kunkun (312_CR38) 2019; 18
G Miaomiao (312_CR51) 2021; 112
W Liang (312_CR43) 2016; 7
Z Weide (312_CR78) 2020; 13
Z Ke (312_CR36) 2020; 20
Z Bing (312_CR3) 2017; 8
X Chuhai (312_CR7) 2018; 97
Xu Ke (312_CR35) 2020; 65
J Lin (312_CR46) 2016; 78
Li Tong-Huai (312_CR73) 2018; 97
L-P Tang (312_CR71) 2018; 22
I Farhad (312_CR15) 2020; 17
C Daniela (312_CR9) 2020; 9
W Qunli (312_CR64) 2018; 14
T Lei (312_CR39) 2019; 239
Y Bin (312_CR2) 2018
Xu Caihui (312_CR4) 2018; 8
M Mai (312_CR50) 2020; 84
Z Mingzhu (312_CR53) 2020; 42
Hu Yingying (312_CR95) 2017; 6
Hu Jiang Huijuan (312_CR28) 2017; 12
Y Zhiqiang (312_CR110) 2020; 12
Y Qingqing (312_CR62) 2019; 79
M Guttman (312_CR22) 2012; 482
S-D Hao (312_CR23) 2020; 24
E Farbod (312_CR14) 2019; 19
Xu He Pan (312_CR24) 2020; 34
Lv Jun (312_CR34) 2018; 101
S Zhulei (312_CR112) 2019; 11
ZQ Li (312_CR41) 2017; 46
Z-J Xiong (312_CR85) 2018; 22
L Shuang (312_CR68) 2017; 608
L Shan (312_CR65) 2018; 119
YH Lin (312_CR47) 2020; 9
Li Xia (312_CR79) 2020; 69
S Claudia (312_CR8) 2020; 29
K Peng (312_CR58) 2018; 11
W Pan (312_CR56) 2020; 39
L Pei-Chin (312_CR57) 2016; 16
L Li (312_CR40) 2017; 21
Z Zhao (312_CR105) 2018; 15
Lu Yebin (312_CR92) 2018; 2018
Y Fu-Bing (312_CR17) 2020; 26
S Fan (312_CR13) 2017; 95
Hu Zhou Qiang (312_CR111) 2020; 28
R-W Yao (312_CR91) 2019; 21
Z Hui-Yuan (312_CR27) 2016; 22
H Xiufu (312_CR86) 2018; 674
Q Li (312_CR42) 2019; 109
HW Yuan (312_CR99) 2020; 12
Gu Lize (312_CR48) 2020; 13
W Xinfeng (312_CR84) 2018; 97
Z Wei (312_CR77) 2020; 12
D Li-Jun (312_CR45) 2017; 484
Y Luo Wenfeng (312_CR49) 2018; 23
RJ Taft (312_CR70) 2010; 220
B Zhang (312_CR104) 2020; 24
Li Jun (312_CR31) 2016; 241
F Mingjun (312_CR52) 2019; 30
Y Yang (312_CR90) 2018; 18
Lv Dong (312_CR12) 2020; 13
G Xiao (312_CR80) 2020; 11
W Zhenqiang (312_CR108) 2021; 12
Q Wei (312_CR76) 2019; 509
Li Yang (312_CR89) 2018; 109
Y Ding (312_CR11) 2020
Li Yunsheng (312_CR100) 2019; 860
T Yin (312_CR94) 2020; 11
NJ Protopsaltis (312_CR60) 2019; 22
Li Tonghuai (312_CR72) 2018; 97
W Xuemin (312_CR88) 2019; 24
Z Xiao-Bo (312_CR81) 2016; 19
Li Yihui (312_CR93) 2020; 38
Yu Gan (312_CR18) 2019; 16
L Qian (312_CR61) 2017; 10
Y Xiaoqiu (312_CR83) 2020; 303
Z-Y Zhao (312_CR106) 2019; 23
Z Liang (312_CR44) 2017; 42
Xu Hui Bingqing (312_CR26) 2019; 12
C Ozcan Selahattin (312_CR55) 2020; 470
X Shen (312_CR66) 2020; 11
Z Shenfa (312_CR67) 2019; 120
W Xiaoqiang (312_CR82) 2021; 99
D Qun (312_CR63) 2020; 20
SJ Bensinger (312_CR1) 2012; 23
P Yuqing (312_CR101) 2020; 44
He Chuan (312_CR5) 2018; 48
Z Zhang (312_CR103) 2018; 49
E Zhang (312_CR102) 2014; 5
Yu Wang Heping (312_CR75) 2018; 26
X Chu-Hai (312_CR6) 2016; 37
A Feraydoon (312_CR16) 2020; 112
Y Xu (312_CR87) 2015; 36
W Sisi (312_CR69) 2021; 42
R Kewei (312_CR37) 2017; 25
G Jin (312_CR29) 2020; 67
E-K Nashwa (312_CR54) 2020; 112
Z Zhenghua (312_CR107) 2019; 51
X Dianhui (312_CR10) 2020; 13
W Yong (312_CR96) 2017; 108
References_xml – volume: 112
  start-page: 4640
  year: 2020
  ident: 312_CR54
  publication-title: Genomics
  doi: 10.1016/j.ygeno.2020.08.005
– volume: 26
  start-page: 627
  year: 2020
  ident: 312_CR17
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v26.i6.627
– volume: 9
  start-page: 828
  year: 2020
  ident: 312_CR9
  publication-title: Cells
  doi: 10.3390/cells9040828
– volume: 112
  start-page: 604
  year: 2021
  ident: 312_CR51
  publication-title: Cancer Sci
  doi: 10.1111/cas.14685
– volume: 39
  start-page: 7
  year: 2020
  ident: 312_CR56
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-020-01742-4
– volume: 12
  start-page: 368
  year: 2021
  ident: 312_CR108
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-021-03645-4
– volume: 18
  start-page: 3002
  year: 2019
  ident: 312_CR38
  publication-title: Exp Ther Med
– volume: 37
  start-page: 15031
  year: 2016
  ident: 312_CR6
  publication-title: Tumour Biol
  doi: 10.1007/s13277-016-5391-5
– volume: 12
  start-page: 65
  year: 2017
  ident: 312_CR28
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-017-0802-3
– volume: 11
  start-page: 3199
  year: 2018
  ident: 312_CR58
  publication-title: Int J Clin Exp Pathol
– volume: 97
  start-page: e0575
  year: 2018
  ident: 312_CR73
  publication-title: Medicine (baltimore)
  doi: 10.1097/MD.0000000000010575
– volume: 220
  start-page: 126
  issue: 2
  year: 2010
  ident: 312_CR70
  publication-title: J Pathol
  doi: 10.1002/path.2638
– volume: 24
  start-page: 4940
  year: 2020
  ident: 312_CR104
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 25
  start-page: 789
  year: 2017
  ident: 312_CR37
  publication-title: Oncol Res
  doi: 10.3727/096504016X14783677992682
– volume: 8
  start-page: 61
  year: 2018
  ident: 312_CR4
  publication-title: Cell Biosci
  doi: 10.1186/s13578-018-0260-0
– volume: 16
  start-page: 583
  year: 2016
  ident: 312_CR57
  publication-title: BMC Cancer
  doi: 10.1186/s12885-016-2569-6
– volume: 23
  start-page: 485
  year: 2018
  ident: 312_CR49
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-181405
– volume: 26
  start-page: 665
  year: 2018
  ident: 312_CR75
  publication-title: Oncol Res
  doi: 10.3727/096504017X14908298412505
– volume: 18
  start-page: 5791
  year: 2018
  ident: 312_CR90
  publication-title: Mol Med Rep
– volume: 12
  start-page: 6837
  year: 2020
  ident: 312_CR77
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S256624
– volume: 470
  start-page: 115
  year: 2020
  ident: 312_CR55
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-020-03751-5
– volume: 16
  start-page: 779
  year: 2018
  ident: 312_CR25
  publication-title: Exp Ther Med
– volume: 108
  start-page: 859
  year: 2017
  ident: 312_CR96
  publication-title: Cancer Sci
  doi: 10.1111/cas.13201
– volume: 23
  start-page: 9781
  year: 2019
  ident: 312_CR106
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 11
  start-page: 65
  issue: 1
  year: 2020
  ident: 312_CR66
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-020-2254-1
– volume: 65
  start-page: 1748
  year: 2020
  ident: 312_CR35
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-019-05911-0
– volume: 46
  start-page: 956
  issue: 10
  year: 2017
  ident: 312_CR41
  publication-title: J Oral Pathol Med
  doi: 10.1111/jop.12599
– volume: 59
  start-page: 226
  year: 2018
  ident: 312_CR19
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2018.59.2.226
– volume: 26
  start-page: 1083
  year: 2018
  ident: 312_CR59
  publication-title: Oncol Res
  doi: 10.3727/096504018X15152085755247
– volume: 24
  start-page: 619
  year: 2020
  ident: 312_CR23
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 109
  start-page: 1793
  year: 2019
  ident: 312_CR42
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.11.003
– volume: 21
  start-page: 542
  issue: 5
  year: 2019
  ident: 312_CR91
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-019-0311-8
– volume: 101
  start-page: 19
  year: 2018
  ident: 312_CR34
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2018.05.010
– volume: 84
  start-page: 38
  year: 2020
  ident: 312_CR50
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2020.06.005
– volume: 95
  start-page: 1636
  year: 2017
  ident: 312_CR13
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.09.076
– volume: 12
  start-page: 563
  year: 2020
  ident: 312_CR110
  publication-title: Am J Transl Res
– volume: 20
  start-page: 8
  year: 2020
  ident: 312_CR63
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-019-1093-6
– volume: 12
  start-page: 11103
  year: 2020
  ident: 312_CR99
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S270515
– volume: 22
  start-page: 3281
  year: 2016
  ident: 312_CR27
  publication-title: Med Sci Monit
  doi: 10.12659/MSM.897072
– volume: 11
  start-page: 3904
  year: 2020
  ident: 312_CR80
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-17667-7
– year: 2018
  ident: 312_CR2
  doi: 10.1042/BSR20180677
– year: 2020
  ident: 312_CR11
  publication-title: Clin Exp Pharm Physiol
  doi: 10.1111/1440-1681.13375
– volume: 10
  start-page: 280
  year: 2019
  ident: 312_CR98
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1509-1
– volume: 44
  start-page: 438
  year: 2020
  ident: 312_CR101
  publication-title: Oncol Rep
  doi: 10.3892/or.2020.7623
– volume: 12
  start-page: 10375
  year: 2019
  ident: 312_CR20
  publication-title: OncoTargets Ther
  doi: 10.2147/OTT.S217795
– volume: 13
  start-page: 5857
  year: 2020
  ident: 312_CR12
  publication-title: OncoTargets Ther
  doi: 10.2147/OTT.S254634
– volume: 97
  start-page: 1375
  year: 2018
  ident: 312_CR84
  publication-title: Ann Hematol
  doi: 10.1007/s00277-018-3315-8
– volume: 14
  start-page: S405
  year: 2018
  ident: 312_CR64
  publication-title: J Cancer Res Ther
  doi: 10.4103/0973-1482.172585
– volume: 97
  start-page: 1645
  year: 2018
  ident: 312_CR7
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.12.004
– volume: 6
  start-page: 471
  year: 2017
  ident: 312_CR95
  publication-title: Cancer Med
  doi: 10.1002/cam4.994
– volume: 78
  start-page: 333
  year: 2016
  ident: 312_CR46
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-016-3066-y
– volume: 119
  start-page: 9694
  year: 2018
  ident: 312_CR65
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.27284
– volume: 51
  start-page: 826
  year: 2019
  ident: 312_CR107
  publication-title: Acta Biochim Biophys Sin (shanghai)
  doi: 10.1093/abbs/gmz069
– volume: 22
  start-page: 7393
  year: 2018
  ident: 312_CR85
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 477
  start-page: 743
  year: 2016
  ident: 312_CR32
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2016.06.129
– volume: 38
  start-page: 1129
  year: 2020
  ident: 312_CR93
  publication-title: Cell Biochem Funct
  doi: 10.1002/cbf.3575
– volume: 30
  start-page: 562
  year: 2019
  ident: 312_CR52
  publication-title: Anticancer Drugs
  doi: 10.1097/CAD.0000000000000734
– volume: 28
  start-page: 204
  year: 2020
  ident: 312_CR111
  publication-title: J Drug Target
  doi: 10.1080/1061186X.2019.1644651
– volume: 48
  start-page: 1928
  year: 2018
  ident: 312_CR5
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000492517
– volume: 42
  start-page: 315
  year: 2021
  ident: 312_CR69
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgaa110
– volume: 241
  start-page: 644
  year: 2016
  ident: 312_CR31
  publication-title: Exp Biol Med (maywood)
  doi: 10.1177/1535370215622708
– volume: 674
  start-page: 87
  year: 2018
  ident: 312_CR86
  publication-title: Gene
  doi: 10.1016/j.gene.2018.06.085
– volume: 5
  start-page: 1243
  year: 2014
  ident: 312_CR102
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2014.201
– volume: 484
  start-page: 598
  year: 2017
  ident: 312_CR45
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2017.01.145
– volume: 608
  start-page: 49
  year: 2017
  ident: 312_CR68
  publication-title: Gene
  doi: 10.1016/j.gene.2017.01.024
– volume: 8
  start-page: 113650
  year: 2017
  ident: 312_CR3
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.21922
– volume: 112
  start-page: 677
  year: 2020
  ident: 312_CR16
  publication-title: Genomics
  doi: 10.1016/j.ygeno.2019.04.020
– volume: 498
  start-page: 70
  year: 2021
  ident: 312_CR30
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.10.031
– volume: 69
  start-page: 897
  year: 2020
  ident: 312_CR79
  publication-title: Inflamm Res
  doi: 10.1007/s00011-020-01388-0
– volume: 19
  start-page: 222
  year: 2019
  ident: 312_CR14
  publication-title: BMC Cancer
  doi: 10.1186/s12885-019-5435-5
– volume: 49
  start-page: 2511
  year: 2018
  ident: 312_CR103
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000493876
– volume: 15
  start-page: 4026
  issue: 3
  year: 2018
  ident: 312_CR105
  publication-title: Oncol Lett
– volume: 19
  start-page: 349
  year: 2016
  ident: 312_CR81
  publication-title: J Breast Cancer
  doi: 10.4048/jbc.2016.19.4.349
– volume: 17
  start-page: 631
  issue: 10
  year: 2020
  ident: 312_CR15
  publication-title: Clin Oncol
– volume: 22
  start-page: 8574
  year: 2018
  ident: 312_CR71
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 11
  start-page: 82
  year: 2020
  ident: 312_CR94
  publication-title: Thorac Cancer
  doi: 10.1111/1759-7714.13236
– volume: 2018
  start-page: 6857042
  year: 2018
  ident: 312_CR92
  publication-title: Dis Markers
– volume: 239
  start-page: 117035
  year: 2019
  ident: 312_CR39
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2019.117035
– volume: 31
  start-page: 592
  year: 2020
  ident: 312_CR21
  publication-title: Anticancer Drugs
  doi: 10.1097/CAD.0000000000000882
– volume: 22
  start-page: 311
  year: 2019
  ident: 312_CR60
  publication-title: Angiogenesis
  doi: 10.1007/s10456-018-9658-x
– volume: 21
  start-page: 5610
  year: 2017
  ident: 312_CR40
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 42
  start-page: 2145
  year: 2017
  ident: 312_CR44
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000479990
– volume: 9
  start-page: 262
  issue: 2
  year: 2020
  ident: 312_CR47
  publication-title: Cells
  doi: 10.3390/cells9020262
– volume: 11
  start-page: 6079
  year: 2019
  ident: 312_CR112
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S200998
– volume: 13
  start-page: 2007
  year: 2020
  ident: 312_CR48
  publication-title: OncoTargets Ther
  doi: 10.2147/OTT.S240434
– volume: 13
  start-page: 2319
  year: 2020
  ident: 312_CR10
  publication-title: OncoTargets Ther
  doi: 10.2147/OTT.S236860
– volume: 99
  start-page: 249
  year: 2021
  ident: 312_CR82
  publication-title: Biochem Cell Biol
  doi: 10.1139/bcb-2020-0017
– volume: 16
  start-page: 257
  year: 2019
  ident: 312_CR18
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2019.02.017
– volume: 15
  start-page: 501
  year: 2005
  ident: 312_CR97
  publication-title: Curr Biol
  doi: 10.1016/j.cub.2005.02.027
– volume: 482
  start-page: 339
  issue: 7385
  year: 2012
  ident: 312_CR22
  publication-title: Nature
  doi: 10.1038/nature10887
– volume: 24
  start-page: 1020
  year: 2019
  ident: 312_CR88
  publication-title: J BUON
– volume: 12
  start-page: 1043
  year: 2019
  ident: 312_CR26
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S188396
– volume: 13
  start-page: 7887
  year: 2020
  ident: 312_CR78
  publication-title: OncoTargets Ther
  doi: 10.2147/OTT.S238189
– volume: 67
  start-page: 751
  year: 2020
  ident: 312_CR29
  publication-title: Neoplasma
  doi: 10.4149/neo_2020_190805N717
– volume: 371
  start-page: 55
  year: 2019
  ident: 312_CR74
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2019.04.005
– volume: 79
  start-page: 47
  year: 2019
  ident: 312_CR62
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2019.10.002
– volume: 120
  start-page: 13392
  year: 2019
  ident: 312_CR67
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.28614
– volume: 34
  start-page: e23540
  year: 2020
  ident: 312_CR24
  publication-title: J Clin Lab Anal
  doi: 10.1002/jcla.23540
– volume: 36
  start-page: 1643
  issue: 3
  year: 2015
  ident: 312_CR87
  publication-title: Tumour Biol
  doi: 10.1007/s13277-014-2763-6
– volume: 29
  start-page: 367
  issue: 5
  year: 2020
  ident: 312_CR8
  publication-title: Eur J Cancer Prev
  doi: 10.1097/CEJ.0000000000000594
– volume: 109
  start-page: 3093
  year: 2018
  ident: 312_CR89
  publication-title: Cancer Sci
  doi: 10.1111/cas.13765
– volume: 20
  start-page: 148
  year: 2020
  ident: 312_CR36
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-020-01474-7
– volume: 97
  start-page: e12131
  year: 2018
  ident: 312_CR72
  publication-title: Medicine (baltimore)
  doi: 10.1097/MD.0000000000012131
– volume: 23
  start-page: 352
  issue: 4
  year: 2012
  ident: 312_CR1
  publication-title: Semin Cell Dev Biol
  doi: 10.1016/j.semcdb.2012.02.003
– volume: 303
  start-page: 3024
  year: 2020
  ident: 312_CR83
  publication-title: Anat Rec (hoboken)
  doi: 10.1002/ar.24367
– volume: 42
  start-page: 2537
  year: 2020
  ident: 312_CR53
  publication-title: Biotechnol Lett
  doi: 10.1007/s10529-020-02984-0
– volume: 10
  start-page: 2461
  year: 2017
  ident: 312_CR61
  publication-title: OncoTargets Ther
  doi: 10.2147/OTT.S136386
– volume: 26
  start-page: e919714
  year: 2020
  ident: 312_CR109
  publication-title: Med Sci Monit
– volume: 860
  start-page: 172536
  year: 2019
  ident: 312_CR100
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2019.172536
– volume: 23
  start-page: 569
  year: 2018
  ident: 312_CR33
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-181834
– volume: 7
  start-page: 51713
  year: 2016
  ident: 312_CR43
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.10563
– volume: 509
  start-page: 56
  year: 2019
  ident: 312_CR76
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.12.011
SSID ssj0021545
Score 2.4608192
SecondaryResourceType review_article
Snippet Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 ( TUG1 ) is...
Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 (TUG1) is...
Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 (TUG1) is...
Abstract Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 (TUG1)...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 51
SubjectTerms Angiogenesis
Animals
Apoptosis
Apoptosis - genetics
Biomarker
Biomarkers, Tumor
Biomedical and Life Sciences
Biomedicine
Bladder cancer
Bone cancer
Breast cancer
Cancer
Cell Cycle
Cell division
Cell growth
Cell Line, Tumor
Cell Movement
Cell Proliferation
Chemotherapy
Competitive endogenous RNA (ceRNA)
Cyclin-dependent kinases
Disease Susceptibility
Drug resistance
Epigenetics
Gene Expression Regulation, Neoplastic - drug effects
Humans
Kidney cancer
Kinases
Long non-coding RNA (lncRNA)
Lung cancer
Metastasis
MicroRNAs
Molecular Medicine
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Neoplasms - therapy
Neovascularization, Pathologic - genetics
Neovascularization, Pathologic - metabolism
Pancreatic cancer
Prostate cancer
Review
RNA, Long Noncoding - genetics
Signal Transduction
Taurine‐upregulated gene 1 (TUG1)
Vascular endothelial growth factor
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtUwELVQBRIbBOUVWiojsYMIJ3Zie9kiKhboClWAurPiF1zpKqnuoxI7PoFv5Es6YycXLs8N29iRnPGx54wyc4aQp-DTvYghlFXgohSedaVyTVV2NdyEnQ_BJbHqD2_kbKbOz_XbH1p9YU5YlgfOhnsB06MQncc-SgK8uXZKNV2SFbea2VTmC6xnCqbGUAuJQc42bEskBVO5jGqxaA5DJkxNQETXpdhxSUm5_3d089esyZ9-nSaPdHqb3BqpJD3On3CHXAv9PrmRm0t-vktOzoZFoEOki6H_SCHKdwP6KXo2O6ZrFBPqw7cvXzcXy9yNPngKWAq0ovOeOsTCcnWPvD999e7l63LsmFA6yeS6dKjGrizT3Nmu8p2PMgJD0NFZbusogo5NEHCnqMZ71ngWpbQsVqKOGtwU4_fJHqwnPCTUgYW5dZWVkgnvhdU1s6kMlQUum6Yg1WQ040Y5cexqsTAprFCtyYY2YOgkQFobUZBn23cuspjGX2ef4F5sZ6IQdnoA8DAjPMy_4FGQw2knzXg6VwZ7ANQtB-5YkCfbYThX-LOk68OwwTmcc6DDXBfkQd747Uq4YEArG1kQuQOJnaXujvTzT0m7W1UQ4LVgvecTeL4v68-mePQ_THFAbtYJ9ZjWeEj21stNeEyuu8v1fLU8SufnCggiGL4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JixQxFH5oj4IX96V0lAjetDBVSVWSk0zLDB6kGRqVuRWVbWxoqtpeBG_-BH-jv8S81DK0y1y8VlLwkrcnL98DeBF8uuXeuTRzjKfc0jqVpsjSOg-WsLbOmQhW_em9mM3k2Zk67Q_cNn1Z5WATo6G2rcEz8teI256XLPj7N6svKXaNwtvVvoXGVThApDI-gYPp8ex0PqZcGCB0VYdlisHB8GxGlvh4DlMnLFFAyc5TvueaIoL_38LOP6snf7tCjZ7p5Nb_ruk23OxjUnLUCdEduOKau3C961L57R5M5-3SkdaTZduck6ZtTIsOj8xnR2SLqESN-_n9x2617traO0uCUDqSkUVDDArVenMfPp4cf3j7Lu1bL6RGULFNDcK6S00VM7rObG298CHUUN5opnPPnfKF48E4ycJaWljqhdDUZzz3Kvg7yh7AJNDjHgExhZJMm0wLQbm1XKuc6vielTomiiKBbNj1yvS45NgeY1nF_ESWVcepKnAqIpnmFU_g5fjPqkPluHT2FJk5zkRE7fihXZ9XvYJWQSw957XFfl08RI3KSFnUEb5eK6plAocDD6tezTfVBQMTeD4OBwXFW5e6ce0O5zDGQlzNVAIPO8kZKWGchvi0EAmIPZnaI3V_pFl8jiDgMguZYhl279UgfRdk_XsrHl--iidwI48KgZWPhzDZrnfuKVwzX7eLzfpZr1y_ANM3KI8
  priority: 102
  providerName: ProQuest
Title Role of long noncoding RNA taurine‐upregulated gene 1 in cancers
URI https://link.springer.com/article/10.1186/s10020-021-00312-4
https://www.ncbi.nlm.nih.gov/pubmed/34039257
https://www.proquest.com/docview/2546263456
https://www.proquest.com/docview/2533316139
https://pubmed.ncbi.nlm.nih.gov/PMC8157665
https://doaj.org/article/deef44ad172848399c885a55986b90b8
Volume 27
WOSCitedRecordID wos000655107800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1076-1551
  databaseCode: RBZ
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: Directory of Open Access Journals
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1076-1551
  databaseCode: DOA
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1076-1551
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1076-1551
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1076-1551
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1528-3658
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021545
  issn: 1076-1551
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD5iG0h74c4WGJWReINITuzE9uOKNoEEVVVgKk9RfBuVqmRK20m88RP4jfsls50LKgwkeImU2K3ck-_4fK6PvwPw0sV0Ta0xcWIIjanGZcxVlsRl6mbCUhujglj12Xs2mfD5XEy7Q2GrPtu935IMM3Vwa577w25-qeNTCjwS05juwJ4Ld9y74-zj2bDM8qSgzTTMY08I-qMyN37HVjgKqv03Uc3fMyZ_2TYN0ej03v_9jvtwt2Of6LiFywO4ZaqHcKetR_ntEYxn9dKg2qJlXZ2jqq5U7UMbmk2O0drrD1Xm6vuPzUXTFrA3Gjn4GZSgRYWUh0-zegyfT08-vXkbd0UWYsUwW8fKC7hziQVRskx0qS2zjlQIqySRqaVG2MxQNw3xTGucaWwZk9gmNLXCRTZMnsCuG485BKQywYlUiWQMU62pFCmW4eQqNoRlWQRJb-tCdQrkvhDGsggrEZ4XrW0KZ5ugWZoWNIJXw2cuWv2Nv_Ye-1c49PTa2eFB3ZwXnSsWDoCW0lL7ylzU8UOhOM_KIFQvBZY8gqMeAEXn0KvClw1Ic-LoZgQvhmbnin5_paxMvfF9CCGOQRMRwUGLl2EkhGLHRDMWAdtC0tZQt1uqxdcg980TtybMnfVe93j6Oaw_m-Lpv3V_BvtpgKRPbTyC3XWzMc_htrpcL1bNCHbYnIUrH8He-GQynY3Cvxfubvruw_TLKLjgNZlGIwg
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtNAFL0qBQQb3g9DgUGCFbUYe8aZ8QKhFqhaNUSoKig743mFSJEd8gB1xyfwJXwUX8LccZwoPLrrgq09scbjc-4jc-dcgCfepxvurI0Ty3jMDS1jqbMkLlNvCUtjrQ5i1R-6oteT_X7-bgN-tGdhsKyytYnBUJta43_kz1G3Pe0w7-9fjj_H2DUKd1fbFhoNLA7tyVefsk1fHLz23_dpmu69OX61Hy-6CsRaUDGLNSqWS-Uzea3KxJTGCee9aO60Yip13OYus9zzTmbG0MxQJ4SiLuGpy70pp8w_9xyc93ZcYAmZ6K8SPAxHmhrHToyhSHtIR3bwqB4malgQgTxKY77mCEO_gL8FuX_Wav62YRv84N7V_20Fr8GVRcRNdhqKXIcNW92Ai00PzpObsHtUjyypHRnV1YBUdaVrdOfkqLdDZqi5VNmf377PxxM7wE5n1hBPOUsSMqyIRspMprfg_Zm8wG3Y9POxd4HoLJdM6UQJQbkxXOUpVeG0LrVMZFkESfuVC71QXcfmH6MiZF-yUzTIKDwygk5rWvAIni1_M240R04dvYvgWY5EvfBwoZ4MioX5KTzpHOelwW5k3MfEuZYyK4M4v8qpkhFstZgpFkZsWqwAE8Hj5W1vfnBPqaxsPccxjDGfNbA8gjsNUpczYZz66DsTEYg1DK9Ndf1ONfwUJM5l4vPgjl-97Rbtq2n9eynunf4Wj-DS_vHbbtE96B3eh8tpICPWeG7B5mwytw_ggv4yG04nDwOtCXw8axb8AuaZhIA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtNAFB2VFhAb3hRDgUGCFVgde8bxeIFQS4mIWqKoAlRWxvNKI0V2yAPUHZ_A9_A5fAn3ju1U4dFdF2ztiTUen3MfmTvnEvIEfLoRztowslyEwrAilDqJwiIGS1gYa7UXq_5wkPb78ugoG6yRH-1ZGCyrbG2iN9Sm0vgf-TbqtscdDv5-2zVlEYO97svJ5xA7SOFOa9tOo4bIvj35Cunb7EVvD7710zjuvn736k3YdBgIdcrSeahRvVwqyOq1KiJTGJc68KiZ04qr2AmbucQK4KBMjGGJYS5NFXORiF0GZp1xeO4FsgEhuQCObQx6bwcfl-keBid1xWMnxMCkPbIjO3hwD9M2LI9AVsWhWHGLvnvA30LePys3f9u-9V6xe-1_Xs_r5GoTi9Odmjw3yJotb5JLdXfOk1tk97AaW1o5Oq7KIS2rUlfo6Olhf4fOUY2ptD-_fV9MpnaIPdCsoUBGSyM6KqlGMk1nt8n7c3mBO2Qd5mPvEqqTTHKlI5WmTBgjVBYz5c_xMsvTJAlI1H7xXDd67NgWZJz7vEx28holOaDEK7jGuQjIs-VvJrUayZmjdxFIy5GoJO4vVNNh3himHOjohCgM9ikTEC1nWsqk8LL9KmNKBmSrxU_emLdZfgqegDxe3gbDhLtNRWmrBY7hnEM-wbOAbNaoXc6ECwZxeZIGJF3B88pUV--Uo2Mvfi4jyJA7sHrPW-SfTuvfS3Hv7Ld4RC4D-PODXn__PrkSe15i8ecWWZ9PF_YBuai_zEez6cOG45R8Om8a_AKF1o7P
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+long+noncoding+RNA+taurine%E2%80%90upregulated+gene+1+in+cancers&rft.jtitle=Molecular+medicine+%28Cambridge%2C+Mass.%29&rft.au=Da%2C+Miao&rft.au=Zhuang%2C+Jing&rft.au=Zhou%2C+Yani&rft.au=Qi%2C+Quan&rft.date=2021-05-26&rft.pub=BioMed+Central&rft.issn=1076-1551&rft.eissn=1528-3658&rft.volume=27&rft.issue=1&rft_id=info:doi/10.1186%2Fs10020-021-00312-4&rft.externalDocID=10_1186_s10020_021_00312_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1076-1551&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1076-1551&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1076-1551&client=summon